APO Research
Talk to an analyst

APO RESEARCH · REPORT

Coartem (Artemether & Lumefantrine)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Coartem (Artemether & Lumefantrine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025182 pages

Choose your research edition.

Industry ResearchCoartem (Artemether & Lumefantrine) Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Coartem (Artemether & Lumefantrine) Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Coartem (Artemether & Lumefantrine) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Coartem (Artemether & Lumefantrine) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Coartem (Artemether & Lumefantrine) Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Coartem (Artemether & Lumefantrine) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Coartem (Artemether & Lumefantrine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Coartem (Artemether & Lumefantrine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Coartem (Artemether & Lumefantrine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Coartem (Artemether & Lumefantrine) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Coartem (Artemether & Lumefantrine) include Novartis, Kunming Pharmaceutical, Kerui Nanhai Pharmaceutical, Guilin Pharmaceutical Co., Ltd, Guangxi Xiancaotang Pharmaceutical Co., LTD, Sanofi-Aventis and KPC Pharmaceuticals, Inc, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Coartem (Artemether & Lumefantrine) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Coartem (Artemether & Lumefantrine) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Coartem (Artemether & Lumefantrine) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Coartem (Artemether & Lumefantrine) market size, projected growth trends, production technologies, key applications, and end-use industries.

Coartem (Artemether & Lumefantrine) Segment by Company

Novartis

Kunming Pharmaceutical

Kerui Nanhai Pharmaceutical

Guilin Pharmaceutical Co., Ltd

Guangxi Xiancaotang Pharmaceutical Co., LTD

Sanofi-Aventis

KPC Pharmaceuticals, Inc

Coartem (Artemether & Lumefantrine) Segment by Type

Artemether

Lumefantrine

Coartem (Artemether & Lumefantrine) Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Coartem (Artemether & Lumefantrine) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Coartem (Artemether & Lumefantrine) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Coartem (Artemether & Lumefantrine) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Coartem (Artemether & Lumefantrine).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Coartem (Artemether & Lumefantrine) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Coartem (Artemether & Lumefantrine) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Coartem (Artemether & Lumefantrine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Coartem (Artemether & Lumefantrine) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Coartem (Artemether & Lumefantrine) Industry Trends Table 2. Coartem (Artemether & Lumefantrine) Industry Drivers Table 3. Coartem (Artemether & Lumefantrine) Industry Opportunities and Challenges Table 4. Coartem (Artemether & Lumefantrine) Industry Restraints Table 5. Global Coartem (Artemether & Lumefantrine) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Coartem (Artemether & Lumefantrine) Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Manufacturers Table 9. Global Coartem (Artemether & Lumefantrine) Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Coartem (Artemether & Lumefantrine) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Coartem (Artemether & Lumefantrine) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Coartem (Artemether & Lumefantrine) Manufacturers, Product Type & Application Table 13. Global Coartem (Artemether & Lumefantrine) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Coartem (Artemether & Lumefantrine) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Artemether Table 17. Major Manufacturers of Lumefantrine Table 18. Global Coartem (Artemether & Lumefantrine) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Coartem (Artemether & Lumefantrine) Sales by Type (2021-2026) & (k units) Table 20. Global Coartem (Artemether & Lumefantrine) Sales by Type (2027-2032) & (k units) Table 21. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Type (2021-2026) Table 22. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Type (2027-2032) Table 23. Global Coartem (Artemether & Lumefantrine) Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2026) & (k units) Table 25. Global Coartem (Artemether & Lumefantrine) Revenue by Type (2027-2032) & (k units) Table 26. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Type (2021-2026) Table 27. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Retail Pharmacy Table 29. Major Manufacturers of Online Pharmacy Table 30. Major Manufacturers of Hospital Pharmacy Table 31. Global Coartem (Artemether & Lumefantrine) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Coartem (Artemether & Lumefantrine) Sales by Application (2021-2026) & (k units) Table 33. Global Coartem (Artemether & Lumefantrine) Sales by Application (2027-2032) & (k units) Table 34. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Application (2021-2026) Table 35. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Application (2027-2032) Table 36. Global Coartem (Artemether & Lumefantrine) Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2026) & (k units) Table 38. Global Coartem (Artemether & Lumefantrine) Revenue by Application (2027-2032) & (k units) Table 39. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Application (2021-2026) Table 40. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Application (2027-2032) Table 41. Global Coartem (Artemether & Lumefantrine) Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Coartem (Artemether & Lumefantrine) Sales by Region (2021-2026) & (k units) Table 43. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Region (2021-2026) Table 44. Global Coartem (Artemether & Lumefantrine) Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Coartem (Artemether & Lumefantrine) Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Coartem (Artemether & Lumefantrine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026) & (k units) Table 48. North America Coartem (Artemether & Lumefantrine) Sales by Country (2027-2032) & (k units) Table 49. Europe Coartem (Artemether & Lumefantrine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026) & (k units) Table 51. Europe Coartem (Artemether & Lumefantrine) Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Coartem (Artemether & Lumefantrine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Coartem (Artemether & Lumefantrine) Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Country (2027-2032) & (k units) Table 58. Global Coartem (Artemether & Lumefantrine) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Coartem (Artemether & Lumefantrine) Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Coartem (Artemether & Lumefantrine) Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Region (2021-2026) Table 62. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Region (2027-2032) Table 63. Novartis Company Information Table 64. Novartis Business Overview Table 65. Novartis Coartem (Artemether & Lumefantrine) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Novartis Coartem (Artemether & Lumefantrine) Product Portfolio Table 67. Novartis Recent Development Table 68. Kunming Pharmaceutical Company Information Table 69. Kunming Pharmaceutical Business Overview Table 70. Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio Table 72. Kunming Pharmaceutical Recent Development Table 73. Kerui Nanhai Pharmaceutical Company Information Table 74. Kerui Nanhai Pharmaceutical Business Overview Table 75. Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio Table 77. Kerui Nanhai Pharmaceutical Recent Development Table 78. Guilin Pharmaceutical Co., Ltd Company Information Table 79. Guilin Pharmaceutical Co., Ltd Business Overview Table 80. Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Product Portfolio Table 82. Guilin Pharmaceutical Co., Ltd Recent Development Table 83. Guangxi Xiancaotang Pharmaceutical Co., LTD Company Information Table 84. Guangxi Xiancaotang Pharmaceutical Co., LTD Business Overview Table 85. Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Product Portfolio Table 87. Guangxi Xiancaotang Pharmaceutical Co., LTD Recent Development Table 88. Sanofi-Aventis Company Information Table 89. Sanofi-Aventis Business Overview Table 90. Sanofi-Aventis Coartem (Artemether & Lumefantrine) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sanofi-Aventis Coartem (Artemether & Lumefantrine) Product Portfolio Table 92. Sanofi-Aventis Recent Development Table 93. KPC Pharmaceuticals, Inc Company Information Table 94. KPC Pharmaceuticals, Inc Business Overview Table 95. KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Product Portfolio Table 97. KPC Pharmaceuticals, Inc Recent Development Table 98. Key Raw Materials Table 99. Raw Materials Key Suppliers Table 100. Coartem (Artemether & Lumefantrine) Distributors List Table 101. Coartem (Artemether & Lumefantrine) Customers List Table 102. Research Programs/Design for This Report Table 103. Authors List of This Report Table 104. Secondary Sources Table 105. Primary Sources List of Figures Figure 1. Coartem (Artemether & Lumefantrine) Product Image Figure 2. Global Coartem (Artemether & Lumefantrine) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Coartem (Artemether & Lumefantrine) Market Size (2021-2032) & (US$ Million) Figure 4. Global Coartem (Artemether & Lumefantrine) Sales (2021-2032) & (k units) Figure 5. Global Coartem (Artemether & Lumefantrine) Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Coartem (Artemether & Lumefantrine) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Artemether Image Figure 9. Lumefantrine Image Figure 10. Global Coartem (Artemether & Lumefantrine) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Coartem (Artemether & Lumefantrine) Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Type (2021-2032) Figure 13. Global Coartem (Artemether & Lumefantrine) Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Coartem (Artemether & Lumefantrine) Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Type (2021-2032) Figure 16. Retail Pharmacy Image Figure 17. Online Pharmacy Image Figure 18. Hospital Pharmacy Image Figure 19. Global Coartem (Artemether & Lumefantrine) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Coartem (Artemether & Lumefantrine) Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Coartem (Artemether & Lumefantrine) Sales Market Share by Application (2021-2032) Figure 22. Global Coartem (Artemether & Lumefantrine) Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Coartem (Artemether & Lumefantrine) Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Application (2021-2032) Figure 25. North America Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2021-2032) Figure 27. U.S. Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2021-2032) Figure 32. Germany Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2021-2032) Figure 39. China Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Market Share by Country (2021-2032) Figure 47. Brazil Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Coartem (Artemether & Lumefantrine) Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Coartem (Artemether & Lumefantrine) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Figure 58. North America Coartem (Artemether & Lumefantrine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Figure 60. Europe Coartem (Artemether & Lumefantrine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Coartem (Artemether & Lumefantrine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Coartem (Artemether & Lumefantrine) Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Coartem (Artemether & Lumefantrine) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Coartem (Artemether & Lumefantrine) Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Coartem (Artemether & Lumefantrine) Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Artemether
  • Lumefantrine
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Novartis
  • Kunming Pharmaceutical
  • Kerui Nanhai Pharmaceutical
  • Guilin Pharmaceutical Co., Ltd
  • Guangxi Xiancaotang Pharmaceutical Co., LTD
  • Sanofi-Aventis
  • KPC Pharmaceuticals, Inc

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Coartem (Artemether & Lumefantrine) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Coartem (Artemether & Lumefantrine) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Coartem (Artemether & Lumefantrine) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Coartem (Artemether & Lumefantrine) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Coartem (Artemether & Lumefantrine) Market Dynamics
  1. 2.1 Coartem (Artemether & Lumefantrine) Industry Trends
  2. 2.2 Coartem (Artemether & Lumefantrine) Industry Drivers
  3. 2.3 Coartem (Artemether & Lumefantrine) Industry Opportunities and Challenges
  4. 2.4 Coartem (Artemether & Lumefantrine) Industry Restraints
3 Coartem (Artemether & Lumefantrine) Market by Manufacturers
  1. 3.1 Global Coartem (Artemether & Lumefantrine) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Coartem (Artemether & Lumefantrine) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Coartem (Artemether & Lumefantrine) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Coartem (Artemether & Lumefantrine) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Coartem (Artemether & Lumefantrine) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Coartem (Artemether & Lumefantrine) Manufacturers, Product Type & Application
  7. 3.7 Global Coartem (Artemether & Lumefantrine) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Coartem (Artemether & Lumefantrine) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Coartem (Artemether & Lumefantrine) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Coartem (Artemether & Lumefantrine) Tier 1, Tier 2, and Tier 3
4 Coartem (Artemether & Lumefantrine) Market by Type
  1. 4.1 Coartem (Artemether & Lumefantrine) Type Introduction
  2. 4.1.1 Artemether
  3. 4.1.2 Lumefantrine
  4. 4.2 Global Coartem (Artemether & Lumefantrine) Sales by Type
  5. 4.2.1 Global Coartem (Artemether & Lumefantrine) Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Coartem (Artemether & Lumefantrine) Sales by Type (2021-2032)
  7. 4.2.3 Global Coartem (Artemether & Lumefantrine) Sales Market Share by Type (2021-2032)
  8. 4.3 Global Coartem (Artemether & Lumefantrine) Revenue by Type
  9. 4.3.1 Global Coartem (Artemether & Lumefantrine) Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Coartem (Artemether & Lumefantrine) Revenue by Type (2021-2032)
  11. 4.3.3 Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Type (2021-2032)
5 Coartem (Artemether & Lumefantrine) Market by Application
  1. 5.1 Coartem (Artemether & Lumefantrine) Application Introduction
  2. 5.1.1 Retail Pharmacy
  3. 5.1.2 Online Pharmacy
  4. 5.1.3 Hospital Pharmacy
  5. 5.2 Global Coartem (Artemether & Lumefantrine) Sales by Application
  6. 5.2.1 Global Coartem (Artemether & Lumefantrine) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Coartem (Artemether & Lumefantrine) Sales by Application (2021-2032)
  8. 5.2.3 Global Coartem (Artemether & Lumefantrine) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Coartem (Artemether & Lumefantrine) Revenue by Application
  10. 5.3.1 Global Coartem (Artemether & Lumefantrine) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Coartem (Artemether & Lumefantrine) Revenue by Application (2021-2032)
  12. 5.3.3 Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Application (2021-2032)
6 Global Coartem (Artemether & Lumefantrine) Sales by Region
  1. 6.1 Global Coartem (Artemether & Lumefantrine) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Coartem (Artemether & Lumefantrine) Sales by Region (2021-2032)
  3. 6.2.1 Global Coartem (Artemether & Lumefantrine) Sales by Region (2021-2026)
  4. 6.2.2 Global Coartem (Artemether & Lumefantrine) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Coartem (Artemether & Lumefantrine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Coartem (Artemether & Lumefantrine) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Coartem (Artemether & Lumefantrine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Coartem (Artemether & Lumefantrine) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Coartem (Artemether & Lumefantrine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Coartem (Artemether & Lumefantrine) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Coartem (Artemether & Lumefantrine) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Coartem (Artemether & Lumefantrine) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Coartem (Artemether & Lumefantrine) Revenue by Region
  1. 7.1 Global Coartem (Artemether & Lumefantrine) Revenue by Region
  2. 7.1.1 Global Coartem (Artemether & Lumefantrine) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Coartem (Artemether & Lumefantrine) Revenue by Region (2021-2026)
  4. 7.1.3 Global Coartem (Artemether & Lumefantrine) Revenue by Region (2027-2032)
  5. 7.1.4 Global Coartem (Artemether & Lumefantrine) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Coartem (Artemether & Lumefantrine) Revenue (2021-2032)
  8. 7.2.2 North America Coartem (Artemether & Lumefantrine) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Coartem (Artemether & Lumefantrine) Revenue (2021-2032)
  11. 7.3.2 Europe Coartem (Artemether & Lumefantrine) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Coartem (Artemether & Lumefantrine) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Coartem (Artemether & Lumefantrine) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Coartem (Artemether & Lumefantrine) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Coartem (Artemether & Lumefantrine) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis Coartem (Artemether & Lumefantrine) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis Coartem (Artemether & Lumefantrine) Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Kunming Pharmaceutical
  8. 8.2.1 Kunming Pharmaceutical Company Information
  9. 8.2.2 Kunming Pharmaceutical Business Overview
  10. 8.2.3 Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Kunming Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio
  12. 8.2.5 Kunming Pharmaceutical Recent Developments
  13. 8.3 Kerui Nanhai Pharmaceutical
  14. 8.3.1 Kerui Nanhai Pharmaceutical Company Information
  15. 8.3.2 Kerui Nanhai Pharmaceutical Business Overview
  16. 8.3.3 Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Kerui Nanhai Pharmaceutical Coartem (Artemether & Lumefantrine) Product Portfolio
  18. 8.3.5 Kerui Nanhai Pharmaceutical Recent Developments
  19. 8.4 Guilin Pharmaceutical Co., Ltd
  20. 8.4.1 Guilin Pharmaceutical Co., Ltd Company Information
  21. 8.4.2 Guilin Pharmaceutical Co., Ltd Business Overview
  22. 8.4.3 Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Guilin Pharmaceutical Co., Ltd Coartem (Artemether & Lumefantrine) Product Portfolio
  24. 8.4.5 Guilin Pharmaceutical Co., Ltd Recent Developments
  25. 8.5 Guangxi Xiancaotang Pharmaceutical Co., LTD
  26. 8.5.1 Guangxi Xiancaotang Pharmaceutical Co., LTD Company Information
  27. 8.5.2 Guangxi Xiancaotang Pharmaceutical Co., LTD Business Overview
  28. 8.5.3 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Guangxi Xiancaotang Pharmaceutical Co., LTD Coartem (Artemether & Lumefantrine) Product Portfolio
  30. 8.5.5 Guangxi Xiancaotang Pharmaceutical Co., LTD Recent Developments
  31. 8.6 Sanofi-Aventis
  32. 8.6.1 Sanofi-Aventis Company Information
  33. 8.6.2 Sanofi-Aventis Business Overview
  34. 8.6.3 Sanofi-Aventis Coartem (Artemether & Lumefantrine) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sanofi-Aventis Coartem (Artemether & Lumefantrine) Product Portfolio
  36. 8.6.5 Sanofi-Aventis Recent Developments
  37. 8.7 KPC Pharmaceuticals, Inc
  38. 8.7.1 KPC Pharmaceuticals, Inc Company Information
  39. 8.7.2 KPC Pharmaceuticals, Inc Business Overview
  40. 8.7.3 KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 KPC Pharmaceuticals, Inc Coartem (Artemether & Lumefantrine) Product Portfolio
  42. 8.7.5 KPC Pharmaceuticals, Inc Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Coartem (Artemether & Lumefantrine) Value Chain Analysis
  2. 9.1.1 Coartem (Artemether & Lumefantrine) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Coartem (Artemether & Lumefantrine) Production Mode & Process
  6. 9.2 Coartem (Artemether & Lumefantrine) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Coartem (Artemether & Lumefantrine) Distributors
  9. 9.2.3 Coartem (Artemether & Lumefantrine) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst